AbbVie (ABBV) EBIT (2012 - 2026)
AbbVie (ABBV) recorded EBIT of $6.43 billion in Q2 2026, up 31.4% from $4.89 billion a year earlier and up 61.2% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) EBIT (2012 - 2026) Analysis & Trends
On a TTM basis, AbbVie's EBIT came in at $16.87 billion as of Jun 30, 2026, up 53.8% year-over-year; for FY2025, it was $15.08 billion, up 65.0% from FY2024.
- Annual EBIT has a five-year compound annual growth rate of 5.8% (FY2020 to FY2025).
- Across earlier years, EBIT came in at $9.14 billion in FY2024 (-28.4%), $12.76 billion in FY2023 (-29.6%), $18.12 billion in FY2022 (+1.1%) and $17.92 billion in FY2021 (+57.7%).
- The Q2 2026 figure is the highest quarterly EBIT in data going back to Q1 2012.
- On a year-over-year basis, EBIT rose in five of the last six quarters, with growth averaging 18.6%.
- Peak year-over-year performance for EBIT in the last five years was growth of 68.0% in Q3 2024, against a decline of 50.4% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $3.99 billion (Q1 2026), $4.54 billion (Q4 2025) and $1.9 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 360.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.43 Bn |
| Mar 31, 2026 | 3.99 Bn |
| Dec 31, 2025 | 4.54 Bn |
| Sep 30, 2025 | 1.90 Bn |
| Jun 30, 2025 | 4.89 Bn |
| Mar 31, 2025 | 3.73 Bn |
| Dec 31, 2024 | -1.49 Bn |
| Sep 30, 2024 | 3.83 Bn |
| Jun 30, 2024 | 4.00 Bn |
| Mar 31, 2024 | 2.80 Bn |
| Dec 31, 2023 | 3.20 Bn |
| Sep 30, 2023 | 2.28 Bn |
| Jun 30, 2023 | 4.51 Bn |
| Mar 31, 2023 | 2.77 Bn |
| Dec 31, 2022 | 5.50 Bn |
| Sep 30, 2022 | 4.60 Bn |
| Jun 30, 2022 | 3.30 Bn |
| Mar 31, 2022 | 4.72 Bn |
| Dec 31, 2021 | 5.07 Bn |
| Sep 30, 2021 | 4.31 Bn |
API Access
AbbVie EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();